Literature DB >> 27544821

Cellular transduction mechanisms of adeno-associated viral vectors.

Garrett Edward Berry1, Aravind Asokan2.   

Abstract

Recombinant adeno-associated viral vectors (rAAV) are regarded as promising vehicles for therapeutic gene delivery. Continued development and new strategies are essential to improve the potency of AAV vectors and reduce the effective dose needed for clinical efficacy. In this regard, many studies have focused on understanding the cellular transduction mechanisms of rAAV, often with the goal of exploiting this knowledge to increase gene transfer efficiency. Here, we provide an overview of our evolving understanding of rAAV cellular trafficking pathways through the host cell, beginning with cellular entry and ending with transcription of the vector genome. Strategies to exploit this information for improving rAAV transduction are discussed. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27544821      PMCID: PMC5138113          DOI: 10.1016/j.coviro.2016.08.001

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  59 in total

1.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  AAV transcytosis through barrier epithelia and endothelium.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  Mol Ther       Date:  2005-12-20       Impact factor: 11.454

3.  rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion.

Authors:  Wei Ding; Liang N Zhang; Charles Yeaman; John F Engelhardt
Journal:  Mol Ther       Date:  2006-01-25       Impact factor: 11.454

4.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Seok-Hong Min; Vince Chiodo; Ji-Jing Pang; Li Zhong; Sergei Zolotukhin; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

Review 5.  Parvovirus glycan interactions.

Authors:  Lin-Ya Huang; Sujata Halder; Mavis Agbandje-McKenna
Journal:  Curr Opin Virol       Date:  2014-07-19       Impact factor: 7.090

6.  Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Authors:  S Sanlioglu; P K Benson; J Yang; E M Atkinson; T Reynolds; J F Engelhardt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo.

Authors:  K Qing; B Khuntirat; C Mah; D M Kube; X S Wang; S Ponnazhagan; S Zhou; V J Dwarki; M C Yoder; A Srivastava
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.

Authors:  Mathieu E Nonnenmacher; Jean-Christophe Cintrat; Daniel Gillet; Thomas Weber
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

9.  Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.

Authors:  Joshua C Grieger; Jarrod S Johnson; Brittney Gurda-Whitaker; Mavis Agbandje-McKenna; R Jude Samulski
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  Super-resolution imaging of nuclear import of adeno-associated virus in live cells.

Authors:  Joseph M Kelich; Jiong Ma; Biao Dong; Qizhao Wang; Mario Chin; Connor M Magura; Weidong Xiao; Weidong Yang
Journal:  Mol Ther Methods Clin Dev       Date:  2015-12-02       Impact factor: 6.698

View more
  21 in total

1.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

2.  Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.

Authors:  Anna C Maurer; Matthew D Weitzman
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

3.  A CRISPR Screen Identifies the Cell Polarity Determinant Crumbs 3 as an Adeno-associated Virus Restriction Factor in Hepatocytes.

Authors:  Victoria J Madigan; Tyne O Tyson; Julianne A Yuziuk; Minakshi Pillai; Sven Moller-Tank; Aravind Asokan
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 4.  Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss.

Authors:  Fan Wu; Kumar Sambamurti; Suhua Sha
Journal:  J Assoc Res Otolaryngol       Date:  2022-08-24

Review 5.  Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.

Authors:  Denise E Sabatino; Frederic D Bushman; Randy J Chandler; Ronald G Crystal; Beverly L Davidson; Ricardo Dolmetsch; Kevin C Eggan; Guangping Gao; Irene Gil-Farina; Mark A Kay; Douglas M McCarty; Eugenio Montini; Adora Ndu; Jing Yuan
Journal:  Mol Ther       Date:  2022-06-10       Impact factor: 12.910

6.  ATF6-Mediated Unfolded Protein Response Facilitates Adeno-associated Virus 2 (AAV2) Transduction by Releasing the Suppression of the AAV Receptor on Endoplasmic Reticulum Stress.

Authors:  Mengtian Cui; Qingfang Zhao; Jing Wang; Yang Si; Shan Cheng; Wei Ding
Journal:  J Virol       Date:  2021-12-01       Impact factor: 6.549

7.  Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species.

Authors:  Mohammadsharif Tabebordbar; Kim A Lagerborg; Alexandra Stanton; Emily M King; Simon Ye; Liana Tellez; Allison Krunnfusz; Sahar Tavakoli; Jeffrey J Widrick; Kathleen A Messemer; Emily C Troiano; Behzad Moghadaszadeh; Bryan L Peacker; Krystynne A Leacock; Naftali Horwitz; Alan H Beggs; Amy J Wagers; Pardis C Sabeti
Journal:  Cell       Date:  2021-09-09       Impact factor: 66.850

Review 8.  Emerging Role of Long Non-Coding RNAs in Diabetic Vascular Complications.

Authors:  Vinay Singh Tanwar; Marpadga A Reddy; Rama Natarajan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

Review 9.  Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.

Authors:  Julien Baruteau; Simon N Waddington; Ian E Alexander; Paul Gissen
Journal:  J Inherit Metab Dis       Date:  2017-05-31       Impact factor: 4.982

10.  Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.

Authors:  Sirika Pillay; Wei Zou; Fang Cheng; Andreas S Puschnik; Nancy L Meyer; Safder S Ganaie; Xuefeng Deng; Jonathan E Wosen; Omar Davulcu; Ziying Yan; John F Engelhardt; Kevin E Brown; Michael S Chapman; Jianming Qiu; Jan E Carette
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.